ADAMTS9 and breast cancer: Liu et al. (2018c) proposed a prognostic 5-lncRNA Expression signature for patients with head and neck squamous cell carcinoma. Fan, Ma & Liu, (2018) constructed a competing endogenous RNA (ceRNA) network with lncRNA-miRNA-mRNA and identified a four-lncRNA signature (ADAMTS9-AS1, LINC00536, AL391421.1 and LINC00491) that could independently predict overall survival (OS) in breast cancer (BC) patients.